• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reanalysis of a Phase 3 Trial of a Monthly Extended-Release Risperidone Injection for the Treatment of Acute Schizophrenia.

作者信息

Le Moigne Anne, Fava Maurizio, Csernansky John, Newcomer John W, Graham James

出版信息

J Clin Psychopharmacol. 2021;41(1):76-77. doi: 10.1097/JCP.0000000000001319.

DOI:10.1097/JCP.0000000000001319
PMID:33208710
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7752235/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf5/7752235/cf58fcdbb24d/jcp-41-76-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf5/7752235/cf58fcdbb24d/jcp-41-76-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf5/7752235/cf58fcdbb24d/jcp-41-76-g001.jpg

相似文献

1
Reanalysis of a Phase 3 Trial of a Monthly Extended-Release Risperidone Injection for the Treatment of Acute Schizophrenia.一项关于每月注射长效利培酮治疗急性精神分裂症的3期试验的重新分析。
J Clin Psychopharmacol. 2021;41(1):76-77. doi: 10.1097/JCP.0000000000001319.
2
Monthly Extended-Release Risperidone (RBP-7000) in the Treatment of Schizophrenia: Results From the Phase 3 Program.每月一次的利培酮延长释放剂（RBP-7000）治疗精神分裂症：来自 3 期项目的结果。
J Clin Psychopharmacol. 2019 Sep-Oct;39(5):428-433. doi: 10.1097/JCP.0000000000001076.
3
Hospitalization risk in patients with schizophrenia before and after initiation of risperidone long-acting injection in Japan.日本精神分裂症患者在开始使用利培酮长效注射剂之前和之后的住院风险。
Asian J Psychiatr. 2015 Apr;14:67-8. doi: 10.1016/j.ajp.2015.02.001. Epub 2015 Feb 11.
4
A comparison of serum prolactin concentrations after administration of paliperidone extended-release and risperidone tablets in patients with schizophrenia.比较帕利哌酮长效制剂与利培酮片治疗精神分裂症患者的血清催乳素浓度。
J Psychopharmacol. 2010 Jul;24(7):1011-8. doi: 10.1177/0269881109106914. Epub 2009 Oct 13.
5
Efficacy, Safety, and Tolerability of RBP-7000 Once-Monthly Risperidone for the Treatment of Acute Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study.每月一次利培酮RBP-7000治疗急性精神分裂症的疗效、安全性和耐受性：一项为期8周的随机、双盲、安慰剂对照、多中心3期研究。
J Clin Psychopharmacol. 2016 Apr;36(2):130-40. doi: 10.1097/JCP.0000000000000479.
6
A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia.棕榈酸帕利哌酮与利培酮长效注射剂治疗精神分裂症的比较研究。
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):1002-8. doi: 10.1016/j.pnpbp.2011.02.001. Epub 2011 Feb 18.
7
A pilot double-blind, dose-comparison study of risperidone in drug-naive, first-episode schizophrenia.一项关于利培酮在未使用过药物的首发精神分裂症患者中的双盲、剂量比较的先导性研究。
J Clin Psychiatry. 2001 Dec;62(12):994-5. doi: 10.4088/jcp.v62n1214c.
8
Risperidone vs. placebo for schizophrenia.利培酮与安慰剂治疗精神分裂症的对比
Am Fam Physician. 2010 May 1;81(9):1096.
9
Monthly administration of long-acting injectable risperidone and striatal dopamine D2 receptor occupancy for the management of schizophrenia.长效注射用利培酮的每月给药及纹状体多巴胺D2受体占有率用于精神分裂症的治疗
J Clin Psychiatry. 2008 Aug;69(8):1281-6. doi: 10.4088/jcp.v69n0811.
10
Paliperidone palmitate versus oral risperidone and risperidone long-acting injection in patients with recently diagnosed schizophrenia: a tolerability and efficacy comparison.棕榈酸帕利哌酮与口服利培酮和利培酮长效注射剂治疗近期诊断为精神分裂症患者的疗效和耐受性比较。
Int Clin Psychopharmacol. 2014 Jan;29(1):45-55. doi: 10.1097/YIC.0000000000000006.

本文引用的文献

1
Monthly Extended-Release Risperidone (RBP-7000) in the Treatment of Schizophrenia: Results From the Phase 3 Program.每月一次的利培酮延长释放剂（RBP-7000）治疗精神分裂症：来自 3 期项目的结果。
J Clin Psychopharmacol. 2019 Sep-Oct;39(5):428-433. doi: 10.1097/JCP.0000000000001076.
2
Effects of Treatment Discontinuation in Clinical Psychopharmacology.临床精神药理学中治疗中断的影响。
Psychother Psychosom. 2019;88(2):65-70. doi: 10.1159/000497334. Epub 2019 Mar 28.
3
Efficacy, Safety, and Tolerability of RBP-7000 Once-Monthly Risperidone for the Treatment of Acute Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study.
每月一次利培酮RBP-7000治疗急性精神分裂症的疗效、安全性和耐受性：一项为期8周的随机、双盲、安慰剂对照、多中心3期研究。
J Clin Psychopharmacol. 2016 Apr;36(2):130-40. doi: 10.1097/JCP.0000000000000479.
4
Compliance with medication regimens for mental and physical disorders.对精神和身体疾病药物治疗方案的依从性。
Psychiatr Serv. 1998 Feb;49(2):196-201. doi: 10.1176/ps.49.2.196.
5
Factors influencing relapse in the long-term course of schizophrenia.精神分裂症长期病程中影响复发的因素。
Schizophr Res. 1997 Dec 19;28(2-3):199-206. doi: 10.1016/s0920-9964(97)00131-x.